Nucor earnings beat by $0.08, revenue fell short of estimates
On Friday, Bernstein SocGen Group reinstated coverage on Demant A/S (DEMANT:DC) (OTC: WILYY) with a Market Perform rating and set a price target of DKK271.00. The firm highlighted that Demant’s valuation, at 17.5 times its estimated 2025 earnings per share (EPS), is considered low when compared to its historical averages and its peer Sonova, which trades at 23.5 times its 2025/26 EPS. According to InvestingPro data, Demant currently trades at a P/E of 22.78x and appears undervalued based on Fair Value analysis. The stock is trading near its 52-week low, with a robust gross margin of 76.23%.
Bernstein’s analysis suggests that while Sonova has made advances with its recently launched Sphere product improving speech comprehension in noisy environments, Demant is also expected to introduce competitive enhancements in its future product offerings. This innovation is anticipated to help Demant maintain its long-term market share through a process of mean reversion. InvestingPro analysis reveals the company maintains strong financial health, with 8 additional exclusive insights available to subscribers.
Despite these prospects, the analyst noted that Demant is not expected to launch a new product for another 12 to 18 months. This delay, combined with the headwinds from managed care contract losses observed in the first quarter and the potential for a sequential decline in the wholesale business at the start of the year, indicates that 2025 may present challenges for the company with limited triggers for a change in stock valuation.
In terms of financial projections, Bernstein forecasts a compound annual growth rate (CAGR) of 7% for Demant’s top-line from 2024 to 2029. For the adjusted EPS, the growth is expected to be around 13%. The analysis by Bernstein suggests a cautious outlook for Demant as it navigates through immediate business challenges while planning for future product development.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.